News
The Electronics of the Future
TAU researchers develop ultra-efficient graphene switch at the nanometer scale The research team A team of researchers from Tel Aviv University, in collaboration with colleagues from Japan, has taken an important step toward the next generation of electronics. The scientists achieved highly precise control of the internal structure of graphene — an exceptionally thin and […]
Read MoreWant to lose weight? Start strength training
A new TAU study shows that strength training is the most effective way to lose weight while preserving muscle mass for both women and men. A new study conducted at the Gray Faculty of Medical and Health Sciences and the Sylvan Adams Sports Science Institute at Tel Aviv University reveals a clear conclusion: strength (resistance) training is the most […]
Read MoreIsraeli Breakthrough: The Brain Can Boost Vaccine Effectiveness
New research reveals that activating the brain’s reward system through positive anticipation strengthens the immune response and increases antibody production Left to right: Dr. Tamar Koren & Prof. Asya Rolls , Photo credit: Nitzan Zohar Can positive anticipation that activates the brain’s reward system strengthen the body’s immune defenses? A new study by Tel Aviv University, the Technion, and […]
Read MoreBreast Cancer and the Brain: A Breakthrough in Understanding Metastasis
For the first time, researchers uncover the biological mechanism that enables breast cancer to spread to the brain, opening new paths for treatment and early detection A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv University, has uncovered a mechanism that allows breast cancer to […]
Read MoreMelanoma’s Hidden Defense Mechanism Revealed
TAU-led study uncovers how cancer cells disable the immune system A new international study led by the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds: melanoma cancer cells paralyze immune cells by secreting extracellular vesicles (EVs), which are tiny, bubble-shaped containers secreted from a given cell. The research team believes that this […]
Read MoreRNA-Based Gene Therapy Offers New Hope for ALS Patients
TAU researchers identify a key molecular mechanism behind ALS and succeed in stopping, and even reversing, nerve degeneration. A new international study led by Tel Aviv University researchers may pave the way for an effective treatment for amyotrophic lateral sclerosis (ALS), a fatal and currently incurable neurodegenerative disease. The team uncovered a previously unknown molecular […]
Read MoreNew Biological Mechanism Boosts Myelin Production in the Brain
TAU researchers discover how to increase myelin production — a finding that could aid treatments for Alzheimer’s and multiple sclerosis. Researchers from Tel Aviv University have discovered a new biological mechanism that enhances the production of myelin — a substance essential for proper brain function and nerve communication. “Our findings may serve as the basis […]
Read MoreLiver Fat, Not Weight, Predicts Health Risks in Obese Children
A new study from Tel Aviv University and Dana Dwek Children’s Hospital shows that obese children can remain healthy if liver fat is kept low — highlighting diet quality as a key factor in preventing disease. A study conducted at Tel Aviv University and Dana Dwek Children’s Hospital in Tel Aviv found that disease can […]
Read MoreMeasuring Memory Through Eye Movements
A new TAU–Ichilov study shows that tracking eye movements can assess memory more accurately than verbal reports, with potential use for infants, Alzheimer’s patients, and brain injury victims. Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (“Ichilov”) have measured subjects’ memory without asking whether they remembered something or not – -simply by tracking their […]
Read MoreInnovative Gene Therapy Preserves Hearing and Balance in Preclinical Study
TAU researchers created a gene therapy that protects against hearing and balance impairments caused by inner ear dysfunction. Scientists from the Gray Faculty of Medical & Health Sciences at Tel Aviv University introduced an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction. According to the researchers, “This treatment constitutes […]
Read MoreIsraeli Breakthrough: First Human Trial of Engineered Spinal Cord
TAU researchers begin to prepare for implantation of engineered spinal cord tissues in humans — a new development that brings fresh hope to paralyzed patients. What if we could restore the ability to walk to people paralyzed by injury or illness? This vision is now moving closer to reality. Three years ago, Tel Aviv University […]
Read MoreBreakthrough at TAU: Blocking One Protein Could Prevent Food Allergy Disease
TAU researchers found that blocking the protein TSLP may prevent a painful, food allergy–driven disease on the rise worldwide. A new study from the Gray Faculty of Medical and Health Sciences at Tel Aviv University may mark a breakthrough in the treatment of Eosinophilic Esophagitis (EoE) — a chronic inflammatory disease of the esophagus caused by food […]
Read MoreWorld’s First mRNA Vaccine Against a Deadly Bacterium
Groundbreaking collaborative research leads to a novel mRNA-based vaccine targeting a lethal bacterial infection Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium. In this groundbreaking study, the researchers […]
Read MoreIs This the Future of Burn Care?
TAU researchers and Sheba Medical Center developed bioengineered skin that accelerates healing time. Researchers from Tel Aviv University and Sheba Tel Hashomer Medical Center have developed an innovative bioengineered skin equivalent for grafting in burn victims. The bioengineered skin produced from the patient’s cells is more stable, robust, and flexible than current treatments, making it […]
Read MoreWhat Happens Inside a Cell Under Stress?
Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous tumor. The new system, called scNET, combines information on gene expression at the single-cell level with information on gene interactions, enabling the identification of important […]
Read MoreClosing the Academic Gender Gap in Israel
Though great progress has been made for gender equality in recent decades, academia today still struggles with a severe underrepresentation of women in senior positions. Even at Tel Aviv University, where women make up 58% of PhD students—They compose only 33% of senior faculty. To help enable women to continue in academia, the Presidential Postdoctoral […]
Read MoreNew PTEN Research Could Transform Autism and Cancer Studies
Is PTEN the key to advancing autism and cancer research? A novel scientific method developed at Tel Aviv University promises to accelerate our understanding of the gene PTEN, a key player in cellular growth. This breakthrough will help scientists better understand how cells grow and divide, potentially leading to advancements in the treatment of various […]
Read MoreThe Future of Memory: Superlubricity Sparks Breakthroughs
A groundbreaking technological advancement from Tel Aviv University has, for the first time, enabled the application of the scientific phenomenon of superlubricity in electronic components. As a result, the research team successfully harnessed frictionless sliding to significantly enhance the performance of memory components in computers and other electronic devices. The study was led by Dr. […]
Read MoreInnovative Technology from TAU researchers can double IVF Success Rates
A new technology developed at Tel Aviv University and implemented at Barzilai Medical Center in Ashkelon has demonstrated a significant increase in the success rates of fertilization, pregnancy, and the birth of a healthy baby through in vitro fertilization (IVF). According to the findings collected thus far, the technology has increased IVF success rates from […]
Read MoreTel Aviv University Shatters Limits with Self-Healing Glass
Breakthrough method revolutionizes agricultural crop improvement for enhanced properties
Read MoreCRISPR Unveils Plant Gene Potential
Breakthrough method revolutionizes agricultural crop improvement for enhanced properties
Read MoreProf. Dan Peer Appointed as Member of the Prestigious American National Academy of Engineering
In recognition of his groundbreaking research developing unique strategies for delivering RNA molecules
Read MoreProf. Ehud Gazit Elected Fellow of the US National Academy of Inventors
The appointment is the highest recognition given by the Academy, awarded to innovators whose inventions have had a decisive impact on quality of life, economic development, and social welfare
Read MoreRemoval of Cancerous Tumors Without Surgery
New technology from Tel Aviv University, combining ultrasound and nanobubbles, destroys tumors, eliminating need for invasive treatments
Read MoreInventive Study to Develop Biological Solutions for Agriculture
Ramot at TAU and ag-biotech company PlantArcBio to collaborate on development of RNAi-based products
Read MoreNew technology will identify patients at risk for serious illness before they become symptomatic
A new technology developed at Tel Aviv University uses artificial intelligence (AI), to identify patients who are at risk of serious illness as a result of blood infections.
Read MoreExperimental Drug Displays Effectiveness in Treating Symptoms of Autism and Alzheimer’s Disease
Has FDA orphan designation for a rare developmental disorder
Read MoreTAU Researchers Identify COVID Proteins that Cause Strokes and Heart Attacks
Findings may help develop drug to halt virus’ damage to blood vessels
Read MoreTAU researchers prove that silent mutations can predict development of cancer cells
TAU researchers prove that silent mutations can predict development of cancer cells
Read MoreCombating Antibiotic Resistance
Discovery may contribute to new treatments for infectious diseases
Read MoreOnly 2 Atoms Thick – The Smallest Technology in The World
Leading researcher from Tel Aviv University Prof. Moshe Ben Shalom engineered the most minuscule technology worldwide - only two atoms thick!
Read MoreA Novel Method to Remotely Detect Plant Sound Emission, as a Response to Induced Stress
A new system developed by Tel Aviv University’s research team can remotely detect plant sound emission, as a response to induced stress.
Read MoreTel Aviv University is Launching Multidisciplinary Center to Research Practical Climate Change Solutions
Tel Aviv University is launching a first-of-its-kind multidisciplinary Center for Climate Change Action
Read MoreA Study From Tel Aviv University Proves That Led Light Can Kill Coronavirus
Groundbreaking research finds UV-LED diodes efficiently and cheaply disinfect social spaces
Read MoreResearchers at Tel Aviv University proved that the CRISPR genome editing system could be used to treat aggressive metastatic cancer
First in the world: CRISPR-based cancer treatment destroys cancer cells and increases life expectancy in brain and ovarian cancers
Read MoreITTN- Israeli Tech Transfer Network Report for 2019.
We are excited to share with you the Israeli Tech Transfer Network (ITTN) Report for 2019.
Read MoreTel Aviv University researchers develop “antibody cocktail” to treat and prevent Covid-19
Researchers from Tel Aviv University have successfully sequenced thousands of antibodies that when combined into two cocktail doses of three antibodies at a time, it produces an effective anti-corona cocktail that provides protection from Corona for up to several months.
Read MorePYC Sponsors research: Creation of a novel gene therapy delivery technology
Prof. Dan Peer and his team are developing a novel gene therapy delivery technology. PYC Therapeutics have been exploring methods for intra Cellular delivery of a range of high value drug cargoes that can’t be covalently linked to its Cell Penetrating Peptides (CPPs).
Read MoreMATRICELF SELECTED AS A “ONE TO WATCH” IN THIS YEAR’S SPINOFF PRIZE
Matricelf is a spin-off company of Ramot, the technology-transfer company of Tel Aviv University.
Read MoreRAMOT OPEN HOUSE – JULY 2020
Important announcement: The RAMOT@TAU OPEN HOUSE event TOMORROW is going VIRTUAL!!
Read MoreTrobix Bio selected as a “one to watch” in this year’s Spinoff Prize
Trobix Bio is a spin-off company of Ramot, the technology-transfer office of Tel Aviv University.
Read MoreBayer Pharmaceuticals will test new drugs using human heart tissues 3D-printed in Tel Aviv University
New drugs will be tested on 3-D printed human heart tissue In the future: Bayer and TAU plan to screen drug candidates on 3D-printed whole human hearts
Read MoreRAMOT@TAU is collaborating with Biological Industries Israel Beit Haemek Ltd. and the Israel Defense Forces (IDF) to detect antibodies and immune response to Coronavirus using a highly sensitive and specific serological assay developed at TAU
A TAU team led by Prof. Motti Gerlic and Prof. Ariel Munitz, both of TAU's Faculty of Medicine of Tel Aviv University, have developed a new test to add to the current diagnostic arsenal used to detect coronavirus infection. The unique test is serological — a blood test — and measures the presence of three type of antibodies against the virus. RAMOT@TAU is collaborating with the Israel Defense Forces (IDF) to test thousands of soldiers using this test. In addition, a collaboration agreement was signed with Biological Industries Israel Beit Haemek on this assay.
Read MoreNEOVII to Develop a Novel Vaccine for COVID-19 in an Exclusive Partnership With RAMOT@TAU
Neovii, the Swiss-based biopharmaceutical company and a member of Israeli-based Neopharm Group, has signed a research and license agreement with Tel Aviv University's (TAU) RAMOT, its technology transfer company, to work in collaboration with a team led by Professor Jonathan Gershoni of the School of Molecular Cell Biology and Biotechnology to develop a novel and potentially life-saving COVID-19 vaccine.
Read MoreRAMOT@TAU Awarded U.S. Patent for Novel Coronavirus Vaccine Design
The patent covers a vaccine that targets the most vulnerable point in a coronavirus’s structure, through which it penetrates human cells. The patent has been submitted by Ramot, the technology transfer company of Tel-Aviv University and was granted in March by the U.S. patent and trademark office.
Read MoreInnoCan Pharma Collaborates with RAMOT@TAU to Develop a New Revolutionary Approach to Treat the COVID-19 Corona Virus
Under the terms of the Research Agreement, InnoCan and a team led by Prof. Daniel Offen, a leading researcher specializing in Neuroscience and Exosome technology at Tel Aviv University, will collaborate to develop the cell therapy product, based on Prof. Offen's work in the field. Innocan has agreed to fund the research based on agreed milestones, in the aggregate amount of approximately US $450,000 for the first stage.
Read MoreTAU RESEARCHERS FIGHT COVID-19
RAMOT@TAU Calls on Industry to Partner in Developing Novel Technologies and Research Solutions for COVID-19. Join the global efforts to fight COVID-19!
Read MoreEpeius pharma Launch
Epeius pharma develops next generation biological vehicles for delivery of therapeutic proteins into the central nervous system (CNS)
Read MoreJune 2019 Newsletter
Promising Innovation news from Ramot – June 2019 Please click here to read the full newsletter
Read MoreTel Aviv University # 1 in Israel, for the number of Granted US Patents in 2018
Tel Aviv University has been ranked 66th, and first in Israel, for the number of patents it registered in the United States during 2018, according to a ranking of 100 worldwide universities made by the National Academy of Inventors and the Intellectual Property Owners Association (IPO).
Read MoreMF startup -MultiVu Raises $7M to Revolutionize Next Gen 3D Sensor Technologies
Tel Aviv, May 16, 2019 – MultiVu, developing proprietary 3D imaging solutions using a single sensor and deep learning derived algorithms, today announced the completion of a $7M seed round led by Israel’s most active venture investor OurCrowd, Cardumen Capital and Hong Kong based investment firm Junson Capital.
Read MoreRamot at Tel Aviv University Names Keren Primor Cohen CEO
Tel Aviv, Israel, May 5, 2019, Ramot at Tel Aviv University Ltd announced that its Board of Directors has appointed Keren Primor Cohen as Ramot’s new CEO, to be effective from June 2nd, 2019. Keren previously held the position of VP General Counsel and Business Affairs at Ramot.
Read MoreTAU Momentum Fund with another spin off Company – QART Medical finalizes round of venture investment
QART (Quantitative Assisted Reproductive Technologies) Medical, is a clinical-stage MedTech company, addressing the global infertility epidemic. Tel Aviv, Israel, March 19, 2019, Tel Aviv University (TAU), Technology Innovation Momentum Fund, managed by Ramot, TAU’s Business Engagement Center and Chartered Investment Managers, a SEA-based investment management fund announced the completion of an investment round in QART Medical.
Read MoreCollaboration Agreement with Phylogica – siRNA delivery
Phylogica has entered into a Research and Development Collaboration with Ramot, the Business Engagement Center at Tel Aviv University to further develop the research of Professor Dan Peer of Tel Aviv University in Israel.
Read MoreTrobix Bio – a new company launched to tackle antimicrobial resistance
Tel Aviv, Israel, March 6, 2019, Tel Aviv University (TAU), Technology Innovation Momentum Fund, managed by Ramot, TAU’s Business Engagement Center has entered into a license agreement with Trobix Bio, a newly formed start-up company, to develop and commercialize its antimicrobial resistance platform technology. Following the license agreement, Trobix Bio has completed its initial funding round, led by Chartered Opus investment group.
Read MoreRamot Newsletter December 2018
Happy new year from everyone at RAMOT. May you have a spectacular, full of promising innovations New Year! Click here to read our December 2018 newsletter
Read MoreRamot and BioNTech sign license agreement to use novel set of lipids for improved mRNA delivery
Ramot and BioNTech RNA Pharmaceuticals GmbH, a leader in the development of precise and individualized immunotherapies with a broad and rapidly growing clinical pipeline today announced, that they have entered into a license agreement to further explore a set of novel lipids for improved mRNA delivery in various therapeutic indications.
Read MoreDrug candidate may recover vocal abilities lost to ADNP syndrome
Protein snippet normalizes disrupted neural connectivity caused by genetic disorder, Tel Aviv University researchers say
Read MoreA JOINT RESEARCH COLLABORATION WITH A GLOBAL PHARMA COMPANY ON PROTEIN DEGRADATION PLATFORM
TEL AVIV, ISRAEL, October 8th, Tel Aviv University (TAU) through Ramot, its Business Engagement Center, announce the signing of a collaboration agreement with Novartis to explore several applications and uses of a novel platform for identified new targets and modulators of the ubiquitin pathways developed by Prof. Gali Prag from the TAU School of Neurobiology Biochemistry and Biophysics.
Read MoreBsense Bio Therapeutics – a new spin-off
Bsense Bio Therapeutics is our new spin-off for the treatment of neuropathic pain.
Read MoreMay 2018 – Ramot Newsletter
Satisfaction survey results, call for proposals, new videos and startups updates...
Read MoreNew Joint Venture NEMIS Technologies, Formed by Biosynth and Ramot at Tel Aviv University
New Joint Venture NEMIS Technologies, Formed by Biosynth and Ramot at Tel Aviv University Develops Rapid Diagnostic Tests for Pathogenic Bacteria in Food Safety and Clinical Applications
Read More2018 Satisfaction survey results
Bridging between industry and TAU researchers is one of the primary areas in which Ramot strives to succeed. Last February we engaged with a third-party industry expert (https://www.metrics-institute.net/) to conduct an anonymous satisfaction survey with two critical populations: our researchers and our industry partners.
Read MoreAll amazing things come in ONE!
All amazing things come in ONE! A low cost & simple camera design which senses color & depth information from one optical system in one exposure... by Prof. David Mendlovic - Tel Aviv University Come see us at MWC in Barcelona and contact Mr. Oren Calfon, VP Business Development, Ramot - Tel Aviv University - oren.calfon@ramot.org
Read MoreBiosynth Launches the First AquaSpark(TM) Products Stemming from Tel Aviv University Collaboration
Only last August, Ramot at Tel Aviv University and BIOSYNTH AG announced their joint development work on novel detection molecules. The subject of this cooperation is the AquaSpark™ technology for chemiluminescence-based markers. They represent state-of-the-art technology and considerably improve the detection limits of diagnostic tests in comparison to existing conventional systems.
Read MoreRamot Value Enhancement Program – New call for proposals – Joy Ventures
Selected proposals will be funded with amounts of $40,000-$100,000 per annum, for a two-year period, beginning December 15, 2018. The Annual Joy grant initiative aims to promote and contribute to the emerging field of neuro- wellness.
Read MorePromising innovation newsletter January 2018
As the sun rises on the new year, it's a great opportunity to set ambitious goals and think of how to make the most of funding from Ramot’s Value Enhancement programs. Read on to see how you too can transform your promising innovations from ideas to commercialization.
Read MoreDigital health ecosystem in Israel
Lata Hariharan takes an in-depth look at the digital health ecosystem in Israel, finding much to be cheerful about. Recently, pharmaceutical firm Baxter International and Tel Aviv University's tech transfer office Ramot announced joint research initiatives for...
Read MoreBrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS
... its NurOwn® technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University.
Read MoreTata firm ready with tech to reverse antibiotic resistance
Ramot of Tel Aviv University, which counts Tata Industries as a partner, has developed a technology that can potentially reverse antibiotic resistance
Read MoreTel Aviv University Announces Collaboration with Biosynth on Pioneering Chemiluminescent Molecules
"Chemiluminescence, the process that lights up glow sticks, occurs when a chemical reaction produces light. Researchers from Tel Aviv University developed new reagents to visually detect molecular processes inside cells or biological samples."
Read MoreBaxter, Ramot at Tel Aviv University and Tel Aviv Sourasky Medical Center Partner to Bring New Surgical Innovations Worldwide
Agreements will explore potential applications of promising early-stage research in areas of unmet need Goal will be to bring new innovations to help surgeons advance patient care
Read MoreWipro and Ramot at Tel Aviv University Partner for Joint Research in Emerging Technologies
Wipro and Ramot, the Business Engagement Center at Tel Aviv University announced a partnership for joint research in emerging technologies. The partnership envisages the creation of joint research capability at TAU, supported by Wipro to pursue core as well as applied research in fast-developing technologies in the Artificial Intelligence space
Read MoreA new way to combat drug-resistant bacteria
Antimicrobial resistance is one of the biggest threats to global health, affecting anyone, at any age, in any country, according to the World Health Organization. Currently, 700,000 deaths each year are attributed to antimicrobial resistance, a figure which could increase to 10 million a year by 2050 save further intervention. New breakthrough technology from Tel Aviv […]
Read MoreOur VP of Intellectual Property, Shulamit Hirsch, listed on the IAM 300 list of world leading IP strategists
We are honored to have our VP of Intellectual Property, Shulamit Hirsch, listed on the IAM 300 list of world leading IP strategists. Click to read more Learn more about Shulamit
Read MoreRamot at TAU is ranked 43 among the Top 100 Worldwide Universities Granted U.S. Utility Patents in 2016.
Ramot at TAU is ranked 43 among the Top 100 Worldwide Universities Granted U.S. Utility Patents in 2016. The report, which is published by the NAI and IPO, utilizes data acquired from the U.S. Patent and Trademark Office to highlight the important role patents play in university research and innovation. Click here for the full […]
Read MoreBiomed 2016 – From Academy to Industry
“Innovative Companies Get Their Best Ideas from Academic Research” Harvard Business Review / Greg Satell, April 2016.
Read MoreRamot at Tel Aviv University and Merck to collaborate on Antibody-Drug Conjugate research
Tel Aviv, Israel, January 25, 2017 - Ramot, the business engagement company of Tel Aviv University, today announced a sponsored research collaboration agreement with Merck, a leading science and technology company, with the goal of advancing the development of novel Antibody-Drug Conjugates (ADCs) for cancer therapy.
Read MoreRamot, TAU’s Business Engagement Center Company, to launch i3 Equity Partners on campus
Ramot, TAU's Business Engagement Center Company, to launch i3 Equity Partners on campus
Read More
